Insider: Monia Brett P Chief Executive Officer - IONIS PHARMACEUTICALS INC
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 242,662 | 0 | 242,662 |
| Value | $18,148,690.98 | $0.00 | $18,148,690.98 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 03/10/2026 | DDS | 17,591 | Direct | COM | $76.34 | $1,342,909.25 | 242,662 |
| 03/10/2026 | DDS | 16,512 | Direct | COM | $75.47 | $1,246,234.94 | 260,253 |
| 03/09/2026 | DDS | 7,382 | Direct | COM | $74.11 | $547,087.40 | 361,950 |
| 03/09/2026 | DDS | 1,684 | Direct | COM | $75.58 | $127,281.77 | 242,662 |
| 03/09/2026 | DDS | 117,604 | Direct | COM | $75.26 | $8,850,641.83 | 244,346 |
| 02/06/2026 | DDS | 29,430 | Direct | COM | $85.79 | $2,524,820.30 | 254,497 |
| 01/30/2026 | DDS | 62,970 | Direct | COM | $82.72 | $5,208,979.15 | 283,927 |
| 01/16/2026 | DDS | 44,034 | Direct | COM | $74.82 | $3,294,623.88 | 224,683 |
| 10/06/2025 | DDS | 437 | Direct | COM | $69.26 | $30,268.24 | 179,572 |
| 09/03/2025 | DDS | 16,615 | Direct | COM | $59.12 | $982,262.19 | 266,294 |
| 09/03/2025 | DDS | 59,699 | Direct | COM | $61.06 | $3,645,394.07 | 180,009 |
| 09/03/2025 | DDS | 127,500 | Direct | COM | $60.13 | $7,667,046.75 | 180,824 |
| 07/30/2025 | DDS | 2,432 | Direct | COM | $45.00 | $109,440.00 | 179,820 |
| 07/11/2025 | DDS | 1,160 | Direct | COM | $41.74 | $48,416.20 | 179,820 |
| 03/11/2025 | DDS | 140 | Direct | COM | $32.32 | $4,524.80 | 180,980 |
| 02/04/2025 | DDS | 38,843 | Direct | COM | $31.65 | $1,229,462.52 | 180,683 |
| 01/31/2025 | DDS | 13,242 | Direct | COM | $32.45 | $429,655.23 | 219,526 |
| 01/16/2025 | DDS | 33,445 | Direct | COM | $32.63 | $1,091,444.13 | 207,396 |
| 11/12/2024 | DDS | 6,630 | Direct | COM | $38.05 | $252,294.04 | 167,393 |
| 02/16/2024 | DDS | 387 | Direct | COM | $44.49 | $17,218.56 | 173,751 |
| 02/02/2024 | DDS | 23,501 | Direct | COM | $49.37 | $1,160,303.12 | 174,138 |
| 01/25/2024 | DDS | 2,285 | Direct | COM | $51.75 | $118,248.75 | 151,851 |
| 01/17/2024 | DDS | 32,059 | Direct | COM | $50.42 | $1,616,318.60 | 154,136 |
| 12/21/2023 | DDS | 17,500 | Direct | COM | $49.29 | $862,576.75 | 118,111 |
| 12/20/2023 | DDS | 6,500 | Direct | COM | $49.64 | $322,643.10 | 118,111 |
| 1 2 3 Next Last You are at page 1 of 3 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2026 Zacks Investment Research